Developed with Australian Government Commercial Ready Plus Grant
assistance, in conjunction with an Indian Hospital group and having the
emerging markets in mind, the low cost ophthalmic product is used to
treat diabetic retinopathy.
With 40 million known type 1 and type 2 diabetics in India alone, the
early detection and treatment of diabetic retinopathy in the emerging
markets is extremely important for patients to reduce their burden on
Ingeneus developed this product from the ground up, showcasing our
expertise in the development of multidisciplinary products from idea to
practice. Industrial, mechanical, electronic, software and optical
design were among the capabilities required to bring this product to
The product’s transfer to manufacture and clinical trialing is complete with regulatory testing and approvals assured.
To find out more, visit us at www.ingeneus.com.au